BioProcess Insider Interview with Marc Hummersone
Highlighting the rapid proliferation of cell and gene therapies (CGTs), Hummersone described how his company seeks to support downstream processing for emerging therapies.
Highlighting the rapid proliferation of cell and gene therapies (CGTs), Hummersone described how his company seeks to support downstream processing for emerging therapies.